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OBJECTIVE—The study objective was to describe the effect of socioeconomic status (SES) on
mortality among people with type 2 diabetes.
RESEARCH DESIGN AND METHODS—We used a population-based national elec-
tronic diabetes database for 35- to 84-year-olds in Scotland for 2001–2007 linked to mortality
records. SES was derived from an area-based measure with Q5 and Q1 representing the most
deprived and afﬂuent quintiles, respectively. Poisson regression was used to estimate relative
risks (RRs) for mortality among people with type 2 diabetes compared with the population
without diabetes stratiﬁed by age (35–64 and 65–84 years), sex, duration of diabetes (,2 and
$2 years), and SES.
RESULTS—Complete data were available for 210,994 eligible individuals (99.4%), and there
were 33,842 deaths. Absolute mortality from all causes among people with type 2 diabetes
increased with increasing age and socioeconomic deprivation and was higher for men than
women. RR for mortality associated with type 2 diabetes was highest for women aged 35–64
years in Q1with diabetes duration,2 years at 4.83 (95%CI 3.15–7.40) and lowest for men aged
65–84 years in Q5 with diabetes duration $2 years at 1.13 (1.03–1.24).
CONCLUSIONS—SESmodiﬁes the association between type 2 diabetes andmortality so that
RR for mortality is lower among more deprived populations. Age, sex, and duration of diabetes
also interact with type 2 diabetes to inﬂuence RR of mortality. Differences in prevalence of
comorbidities may explain these ﬁndings.
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P revalence of type 2 diabetes is higherin deprived than afﬂuent areas ofdeveloped countries, and socioeco-
nomic deprivation seems to have a more
marked effect on diabetes prevalence
among women than among men in several
populations (1–4). Inequalities in morbid-
ity andmortality from the complications of
both type 1 and type 2 diabetes by individ-
ual or area-based measures of socioeco-
nomic status (SES) have been described
in many studies (5). A review of data col-
lected up to 1995 from a variety of pop-
ulations concluded that mortality rates
among people with diabetes were approx-
imately double those of people in the gen-
eral population (6). However, relative
risks (RRs) of mortality associated with
diabetes seem to have declined in more
recent years (7).
There has been limited investigation
of the role of SES in the association be-
tween type 2 diabetes and mortality. SES
could confound the association between
diabetes and mortality because it is asso-
ciated with both diabetes prevalence and
mortality. Previous studies have de-
scribed higher mortality among people
with diabetes from more deprived areas
or of lower educational achievement than
among people frommore afﬂuent areas or
higher educational achievement, but they
have not described whether the strength
of the association between diabetes and
mortality varied by SES (8,9).
We have used population-based data
to investigate the relationships between
SES and prevalence and mortality of type
2 diabetes in men and women in Scotland
to test the hypothesis that SES confounds
or modiﬁes the association between type
2 diabetes and mortality.
RESEARCH DESIGN AND
METHODS—Population-based data
are available for people with diagnosed
diabetes in Scotland (population 5.1 mil-
lion people) from the Scottish Care
Information–Diabetes Collaboration
(SCI-DC) dataset (10). In brief, the data-
set has existed at a national level since
2000, contains demographic and clinical
data relevant to diabetes care, and is pop-
ulated by daily downloads from primary
and secondary care databases across
Scotland. Data are collated from 995 of
the 1,000 general practices in Scotland
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and from all hospital clinics. The use of a
unique identiﬁer for health records in
Scotland, the Community Health Index
number, allows the capture of data for
all patients with a diagnosis of diabetes
registered with a contributing practice
and tracking ofmovements between prac-
tices, and permits linkage to mortality re-
cords.
An area-based measure of SES can be
assigned to individual people with diabe-
tes on the basis of where they live by using
the Scottish Index of Multiple Depriva-
tion (SIMD) 2006 (see http://www.
scotland.gov.uk/Topics/Statistics/SIMD
for more information). SIMD 2006 com-
bines 31 indicators across seven domains
of income—employment, health, educa-
tion, housing, geographic access, and
crime—and the overall index is generated
from a weighted sum of the seven domain
scores for each datazone, which contains
a median of 769 people and can be iden-
tiﬁed from postcodes. Quintiles of the
index are deﬁned at a national level, and
Q1 and Q5 were used to identify the most
afﬂuent and most deprived quintiles, re-
spectively.
An extract of SCI-DC data was per-
formed in May 2008. The Information
and Statistics Division of the National
Health Service National Services Scotland
(NHS NSS) assigned SIMD using post-
code and linked the SCI-DC extract to
mortality records provided by the General
Register Ofﬁce for Scotland. A research
database containing no identiﬁable infor-
mation was used for analysis. Approval
for the generation and analysis of the
linked dataset was obtained from the SCI-
DC steering committee, the Scottish mul-
ticenter research ethics committee, the
Privacy Advisory Committee of NHSNSS,
and the Caldicott guardians of all 14
Health Boards in Scotland.
The dataset used for this analysis
contained information on people with
type 2 diabetes (conﬁrmed by an algo-
rithm using age at diagnosis and use and
timing of treatment with oral hypoglyce-
mic agents and insulin) who were alive
and aged 35–84 years during the period
2001–2007. An individual’s data were in-
cluded if complete information on date of
birth, sex, SES, and date of death (if ap-
propriate) were available. The numbers of
people and of deaths in the whole popula-
tion of Scotland by age, sex, calendar year,
and quintile of SES were obtained from the
General Register Ofﬁce for Scotland.
The European Standard Population
for 35- to 84-year-olds was used to
estimate age-standardized prevalence of
type 2 diabetes for 2007 by sex and SIMD
quintile. The denominator for estimates
of prevalence was the total population
minus the number of people with type 1
diabetes. The denominators for estimates
of mortality were generated from the total
Scottish population minus the numbers
of people with type 1 diabetes and type 2
diabetes at the midpoint of each year.
Associations between prevalence and SES
were investigated using Poisson regres-
sion with stratiﬁcation by sex and adjust-
ment for age. Relationships between
diabetes and all-cause mortality for
2001–2007 among people with type 2 di-
abetes stratiﬁed by age (35–64 and 65–84
years), sex, duration of diabetes (,2 and
$2 years), and SES were also investigated
using Poisson models to investigate
whether interactions were present. The
strata for age and duration of diabetes
were chosen after combining larger num-
bers of strata into groups with similar ef-
fects. For example, RRs were similar for
strata of duration of diabetes of 2–5, 6–9,
and 10+ years, so data were combined to
give a group with duration $2 years.
Likelihood ratio tests were used to
compare a model without interaction be-
tween type 2 diabetes and SES with a
model with interaction in each age, sex,
and duration stratum.
RESULTS—Data were available for
212,227 people with type 2 diabetes
who were aged between 35 and 84 years
during 2001–2007. Information on SES
was not available for 1,233 individuals
(0.6%) who were excluded from the anal-
ysis. The numbers of people with prevalent
diabetes and population denominators
and their distribution by sex and SES
quintile are given in Table 1. People in
the most deprived quintile and men were
younger among prevalent cases and
deaths than those in the most afﬂuent
quintile and women.
Age-standardized prevalence of type
2 diabetes by SES quintile and sex is
shown in Fig. 1. Prevalence of type 2 di-
abetes was higher in men than in women
and in deprived populations compared
with afﬂuent populations. SES had a
more marked effect on diabetes preva-
lence among women than men: age-
adjusted RR for Q5 versus Q1: 2.00
(95% CI 1.52–2.62) for women and
1.58 (1.20–2.07) for men.
There were 33,842 deaths among
people with type 2 diabetes and 241,200
deaths among people with neither type 1
nor type 2 diabetes in Scotland in 2001–
2007. Age-standardized mortality was
19.47 (95% CI 19.08–19.85) per 1,000
person-years among men with type 2 di-
abetes and 13.40 (13.33–13.47) per
1,000 person-years among men who did
not have diabetes. Comparable estimates
for women were 15.83 (15.43–16.24)
and 8.45 (8.39–8.50), respectively. Age-
standardized mortality rates for people
with type 2 diabetes and the population
without diabetes by sex, SES, and dura-
tion of diabetes are shown in Fig. 2. The
highest absolute mortality rates were ob-
served amongmen in the ﬁrst 2 years after
diagnosis of type 2 diabetes. There was a
marked socioeconomic gradient in mor-
tality across all strata of duration of dia-
betes and in the nondiabetic population.
In most strata, mortality was signiﬁcantly
higher among people with diabetes than
those without diabetes. Death rates
among men in the two most deprived
quintiles who had had type 2 diabetes
for 2–4 years were not signiﬁcantly differ-
ent from those among the population of
nondiabetic men. Men without diabetes
in the two most deprived quintiles have
particularly high mortality.
RRs for all-cause mortality associated
with type 2 diabetes stratiﬁed by age, sex,
duration of diabetes, and SES are shown
in Table 2. RRs were generally higher in
groups with lower absolute mortality risk
and were higher for younger than older
people, for women than for men, and for
more afﬂuent people than more deprived
people. The results of likelihood ratio
tests indicate that models that include
an interaction term between type 2 diabe-
tes and SES ﬁt the data better than models
that do not include an interaction term for
men ,65 years of age with duration of
diabetes of ,2 years and all groups with
duration of diabetes of $2 years regard-
less of sex or age-group.
CONCLUSIONS—Our ﬁndings of in-
creasing prevalence of diabetes associated
with increasing deprivation and a more
marked effect in women than men are
consistent with other studies (1,3,4,11).
These associations reﬂect differences in
obesity prevalence (12). As expected,
marked gradients in mortality by SES
were found regardless of diabetes status,
and absolute risks of mortality were
higher in people with type 2 diabetes
than people without diabetes inmost sub-
groups. Type 2 diabetes is associated with
increased risk ofmortality not only because
it increases the risk of life-threatening
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complications but also because risk factors
such as obesity increase the risk of cardiovas-
cular disease and cancer, as well as diabetes.
Previous studies suggesting that di-
abetes confers approximately double the
risk of mortality compared with a pop-
ulationwithout diabetes took place before
the widespread use of effective ap-
proaches to prevention of cardiovascular
disease. For example, the Nurses’ Health
Study reported age-adjusted RRs of all-
cause mortality among women aged 30–
55 years for 1976–1996 of 3.39 (95% CI
3.08–3.73) for women with a history of
diabetes and no coronary heart disease
(CHD) at baseline compared with women
with neither diabetes nor CHD at baseline
(13). Among 44,230 patients aged 35–89
years in 1992 with prevalent type 2 dia-
betes identiﬁed from the General Practice
Research Database in the U.K. who were
followed up until October 1999, hazard
ratios for all-cause mortality compared
with a matched cohort with no record of
diabetes at any time were 1.77 (1.72–
1.83) for men and 2.13 (2.06–2.20) for
women (14).
Adjusting for age, as these studies did,
obscures the effect of any interaction,
although age-stratiﬁed analyses indicate
lower hazard ratios among older than
younger people in the General Practice
Research Database study (14). We have
shown that age, sex, duration of diabetes,
and SES all modify the effect of type 2
diabetes on RR of mortality. These
multiple interactions make summary
measures of the effect of diabetes on mor-
tality speciﬁc to each study population.
Differences in such summary measures
across populations and time periods
may be partially explained by differences
in population structures. Age-adjusted
RRs for mortality associated with type 2
diabetes in the Scottish population for
2001–2007 were 1.38 (95% CI 1.28–
1.48) for men and 1.67 (1.58–1.77) for
women, with further adjustment for SES
having little effect: 1.35 (1.30–1.40) for
men and 1.62 (1.57–1.67) for women.
RRs of mortality associated with type
2 diabetes seem to be declining over time.
It is not clear whether changes in distri-
bution of age, sex, duration of diabetes,
and SES may have contributed to these
apparent time trends. RR of mortality
among people with diabetes compared
with mortality in the U.K. population as a
whole was 26% (95% CI 8–40) lower in
2006 than in 2001 (7). The decline de-
scribed in this study may partly be due
to the use of the whole population rather
than the nondiabetic population as the
comparison group and the increasing
prevalence of diabetes over this period,
Table 1—Crude prevalence, mortality, numerators, and denominators for each estimate for type 2 diabetes in Scotland 2001–2007
for people aged 35–84 years by sex
Sex
SIMD quintile
1 (least deprived) 2 3 4 5 (most deprived)
Population of Scotland 2007 M 282,617 293,471 285,773 262,888 238,700
F 307,790 318,857 313,689 302,185 282,955
No. of people with type 2 diabetes 2007 M 15,309 18,349 19,962 21,142 21,086
F 10,241 13,296 15,941 18,535 19,872
Crude prevalence 2007 (%) M 5.4 6.3 7.0 8.0 8.8
F 3.3 4.2 5.1 6.1 7.0
Mean (SD) age of people with type 2
diabetes in 2007 (years) M 64.6 (10.7) 64.7 (10.8) 64.4 (10.9) 64.0 (11.0) 62.8 (11.2)
F 66.8 (10.9) 66.8 (11.0) 66.3 (11.1) 66.3 (11.2) 65.2 (11.5)
Proportion (%) of people with type 2
diabetes aged ,65 years in 2007 M 48.4 47.0 47.6 48.8 52.6
F 38.7 38.3 39.4 39.5 42.9
Mean (SD) duration of diabetes among
whole cohort (years) M 7.7 (6.8) 7.7 (6.8) 7.6 (6.6) 7.6 (6.6) 7.4 (6.3)
F 7.5 (6.7) 7.7 (6.8) 7.7 (6.6) 7.8 (6.6) 7.6 (6.3)
No. of deaths among people with type 2
diabetes 2001–2007 M 2,441 3,309 3,922 4,470 4,838
F 1,583 2,302 3,017 3,670 4,290
Mean (SD) age at death of people with type 2
diabetes 2001–2007 (years) M 73.2 (8.2) 73.1 (8.3) 72.2 (8.6) 71.8 (8.6) 70.3 (9.0)
F 75.2 (7.6) 74.5 (7.6) 74.0 (8.1) 73.4 (8.5) 72.5 (8.6)
Proportion (%) of deaths at age ,65 years among
people with type 2 diabetes 2001–2007 M 15.0 15.1 17.8 19.2 23.8
F 10.2 10.8 12.5 14.4 16.7
Duration describes time from diagnosis to end of 2007 or death.
Figure 1—Age-standardized prevalence (and
95% CI) for type 2 diabetes for 35- to 84-year-
olds by sex and quintile of SIMD (1 = most
afﬂuent, 5 = most deprived) for 2001 to 2007.
, Men;■, women.
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resulting in a higher proportion of people
with diabetes in the denominator.
However, a Danish study describing mor-
tality associated with diabetes between
1995 and 2006 also described declines
in standardized mortality ratios with
comparison of mortality in the diabetic
population with that of the nondiabetic
population over time (15). Changes in di-
agnostic criteria for diabetes and in-
creased opportunistic screening for
diabetes might have contributed to lower
RRs of mortality associated with diabetes
in recent years. Increased prescribing of
effective treatments for control of diabe-
tes, hypertension, and dyslipidemia may
also have contributed to increasing survival
of people with diabetes over time (16).
Our ﬁndings that RR of mortality
among people with diabetes were lower
at older age are consistent with the ﬁnd-
ings of other studies (7,15,17). We
found a higher RR of diabetes for mortal-
ity among women thanmen, as havemost
other studies, although the Danish study
reported virtually identical standardized
mortality ratios for men and women
(15). These ﬁndings may relate to differ-
ences by age, sex, and between countries
in distribution of cardiovascular disease
risk factors and comorbidities between
people with and without diabetes. Hyper-
tension, dyslipidemia, and obesity are
strongly associated with diabetes but are
also most prevalent in older men and least
prevalent in younger women in many
countries. In contrast, prevalence of smok-
ing is more similar in men and women in
Denmark than in other countries. A meta-
analysis of 16 studies that included risk fac-
tor data suggests that sex differences in
both all-cause and cardiovascular disease
mortality do not persist after adjusting for
classic risk factors for coronary heart dis-
ease (age, hypertension, total cholesterol
level, and smoking) (18). This suggests
that differences between people with type
2 diabetes compared with people without
diabetes in prevalence of cardiovascular
risk factors may be more marked among
women than men, but further data are
needed to conﬁrm this hypothesis.
The Danish population-based study
also reported higher relative mortality in
people with recently diagnosed diabetes
Figure 2—Age-standardized mortality for people with type 2 diabetes and for the population of
Scotland without diabetes for 2001–2007 stratiﬁed by sex and duration of diabetes.□, General
population (no diabetes); ●, type 2 diabetes.
Table 2—RRs for all-cause mortality for people with type 2 diabetes compared with the Scottish population without type 2 diabetes
aged 35–84 years for the period 2001–2007 stratiﬁed by age, sex, duration of diabetes, and socioeconomic status
Quintile of SES
Duration of diabetes ,2 years
Men aged 35–64 years Men aged 65–84 years Women aged 35–64 years Women aged 65–84 years
Q1 (most afﬂuent) 3.74 (2.57–5.44) 1.88 (1.34–2.64) 4.83 (3.15–7.40) 1.91 (1.40–2.60)
Q2 4.08 (3.08–5.40) 1.72 (1.28–2.31) 4.36 (3.09–6.17) 1.74 (1.34–2.26)
Q3 2.99 (2.27–3.94) 1.48 (1.12–1.95) 4.28 (3.24–5.67) 1.64 (1.29–2.08)
Q4 2.17 (1.67–2.81) 1.37 (1.05–1.78) 3.84 (3.01–4.90) 1.40 (1.15–1.76)
Q5 (most deprived) 1.75 (1.40–2.18) 1.23 (0.94–1.60) 3.13 (2.52–3.89) 1.48 (1.21–1.82)
P (LR test) , 0.0001 0.29 0.23 0.48
Duration of diabetes $2 years
Q1 (most afﬂuent) 3.43 (2.89–4.07) 1.53 (1.34–1.73) 3.85 (3.15–4.69) 1.84 (1.64–2.06)
Q2 2.69 (2.32–3.13) 1.46 (1.31–1.63) 3.51 (2.99–4.12) 1.62 (1.47–1.78)
Q3 2.75 (2.43–3.11) 1.32 (1.20–1.47) 3.25 (2.85–3.70) 1.59 (1.46–1.73)
Q4 2.26 (2.03–2.53) 1.19 (1.08–1.31) 3.10 (2.78–3.46) 1.46 (1.35–1.58)
Q5 (most deprived) 1.75 (1.59–1.92) 1.13 (1.03–1.24) 2.72 (2.47–2.99) 1.43 (1.33–1.54)
P (LR test) , 0.0001 0.0002 0.006 0.003
The results of likelihood ratio tests for interaction between presence of diabetes and SIMD quintile are given in the rows labeled “P (LR test).” LR, likelihood ratio.
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than for people with diabetes of moderate
duration, as we did (15). This could be
explained by increased detection of dia-
betes in people receiving treatment for
other medical conditions (e.g., cardiovas-
cular disease) that increase mortality.
Educational disparities in mortality
have been found to be lower among
adults with diabetes than adults without
diabetes in Italy, Finland, and the U.S.
(9,19,20). It is possible that better control
of cardiovascular risk factors among de-
prived people with diabetes when com-
pared with deprived people without
diabetes could account for this effect by
reducing the risk of comorbidity among
people with diabetes. Our previous work
suggests control of blood pressure, cho-
lesterol levels, and glycemia among peo-
ple with type 2 diabetes are similar across
socioeconomic groups in Scotland (21).
These patterns contrast with unfavorable
trends in risk factor proﬁles by SES ob-
served in the general population. Smok-
ing prevalence in Q1 in people with
diagnosed diabetes (15%) is similar to
that of participants in the Scottish Health
Survey 2008 (15% in men and 14% in
women in Q1), whereas smoking preva-
lence in Q5 is considerably lower among
people with diagnosed diabetes (33% in
both men and women) than among Scot-
tish Health Survey 2008 participants
(40% in men and 39% in women) (22).
Consequently, the lower RR of mortality
associated with diabetes in deprived pop-
ulations may be related to markedly
higher prevalence of life-shortening co-
morbidity among deprived than afﬂuent
people without diabetes.
The strengths of this study include
the population-based nature of the elec-
tronic record of diagnosed diabetes that
captures data from all but 5 of the 1,000
primary care practices in Scotland. Data
completeness in the SCI-DC dataset is
excellent, and mortality data for the
whole study population are available
from data linkage. Data on type of di-
abetes have been validated using age at
diagnosis and prescribing data for insulin
and oral antidiabetic drugs. The use of an
area-based measure of SES rather than an
individual-based measure is a potential
limitation of the study. However, the
small average population size of each
datazone used to create the SIMD (me-
dian ,800 people) makes it preferable
to previous area-based measures. The in-
clusion of the health domain in the mea-
sure of SES does not seem to have a major
effect on the pattern of health inequalities
by SES (23). At present, we have insufﬁ-
cient data to examine time trends in mor-
tality associated with diabetes.
In conclusion, both socioeconomic
deprivation and type 2 diabetes were
associated with increased absolute mor-
tality risk, but relative mortality associ-
ated with type 2 diabetes was lower
among deprived than afﬂuent popula-
tions. Data on the prevalence of risk
factors and their management and co-
morbidity are available for people with
diabetes in Scotland, but similar informa-
tion from the nondiabetic population is
required to explore the role of these
factors in explaining the excess mortality
associated with diabetes. Further research
is required to develop effective interven-
tions to reduce socioeconomic inequal-
ities in the prevalence of type 2diabetes and
its complications, including mortality.
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